voriconazole teva 50 mg tabletti, kalvopäällysteinen
teva pharma b.v. - voriconazolum - tabletti, kalvopäällysteinen - 50 mg - vorikonatsoli
voriconazole teva 200 mg tabletti, kalvopäällysteinen
teva pharma b.v. - voriconazolum - tabletti, kalvopäällysteinen - 200 mg - vorikonatsoli
clopidogrel acino
acino ag - klopidogreeli - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitromboottiset aineet - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.
eutabarb vet. 400 mg/ml injektioneste, liuos
richter pharma ag - pentobarbital sodium - injektioneste, liuos - 400 mg/ml - pentobarbitaali
ancesol 10 mg/ml injektioneste, liuos
richter pharma ag - chlorphenamine maleate - injektioneste, liuos - 10 mg/ml - kloorifeniramiini
diazedor vet. 5 mg/ml injektioneste, liuos
richter pharma ag - diazepam - injektioneste, liuos - 5 mg/ml - diatsepaami
caniphedrin 50 mg tabletti
richter pharma ag - ephedrine hydrochloride - tabletti - 50 mg
caniphedrin 20 mg tabletti
richter pharma ag - ephedrine hydrochloride - tabletti - 20 mg
candesarstad 4 mg tabletti
stada arzneimittel ag - candesartan cilexetil - tabletti - 4 mg - kandesartaani
candesarstad 8 mg tabletti
stada arzneimittel ag - candesartan cilexetil - tabletti - 8 mg - kandesartaani